Innovimmune Biotherapeutics
Pre-clinicalInnovimmune is a privately-held Drug Discovery & Exploratory Development biotechnology company leading the development of novel first-in-class and best-in-class proprietary oral small molecule New Chemical Entity (NCE) immunomodulatory drugs for the treatment of Cancer, Autoimmune Diseases &
Founded
2017
Focus
Small Molecules
About
Innovimmune is a privately-held Drug Discovery & Exploratory Development biotechnology company leading the development of novel first-in-class and best-in-class proprietary oral small molecule New Chemical Entity (NCE) immunomodulatory drugs for the treatment of Cancer, Autoimmune Diseases &
Company Info
TypePrivate
Founded2017
LocationNew York, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile